Related scientific articles (all)

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.

Authors : Shi W, Jiang T, Nuciforo P, Hatzis C, Holmes E, Harbeck N, Sotiriou C, Peña L, Loi S, Rosa DD, Chia S, Wardley A, Ueno T, Rossari J, Eidtmann H, Armour A, Piccart-Gebhart M, Rimm DL, Baselga J, Pusztai L
Year : 2017
Journal : Ann Oncol
Volume : 28
Pages : 128-135

Low dose clofarabine in combination with a standard remission induction in patients 18-60 years with previously untreated intermediate and bad risk acute myeloid leukemia or high risk myelodysplastic syndrome: combined Phase I/II results of the EORTC

Authors : Selleslag D, Suciu S, Meloni G, Muus P, Halkes CJ, Venditti A, Ramadan SM, Pruijt H, Meert L, Vignetti M, Marie JP, Wittnebel S, de Witte T, Amadori S, Willemze R, Baron F
Year : 2017
Journal : Haematologica
Volume : 102(2)
Pages : e47-51

Les Actualités en Médecine factuelle - Edition 2017.

Authors : Sculier JP
Year : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 178-180

Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.

Authors : Sangro B, Martínez-Urbistondo D, Bester L, Bilbao JI, Coldwell DM, Flamen P, Kennedy A, Ricke J, Sharma RA
Year : 2017
Journal : Hepatology
Volume : 66(3)
Pages : 969-982

Societal challenges of precision medicine: Bringing order to chaos.

Authors : Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott MW, Michiels S, Moscow JA, Tejpar S, Lacombe D
Year : 2017
Journal : Eur J Cancer
Volume : 84
Pages : 325-334

Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.

Authors : Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M
Year : 2017
Journal : Chin J Cancer Res
Volume : 29
Pages : 521-532

Management of Anastomosis Leakage Post-RALP: A Simple Trick for a Complex Situation.

Authors : Diamand R, Al Hajj Obeid W, Accarain A, Limani K, Hawaux E, Van Velthoven R, Peltier A
Year : 2017
Journal : Urol Case Rep
Volume : 12
Pages : 28-30

Adjuvant trastuzumab: a 10-year overview of its benefit.

Authors : Lambertini M, Pondé NF, Solinas C, de Azambuja E
Year : 2017
Journal : Expert Rev Anticancer Ther
Volume : 17
Pages : 61-74

Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.

Authors : Buisseret L, Desmedt C, Garaud S, Fornili M, Wang X, Van den Eyden G, de Wind A, Duquenne S, Boisson A, Naveaux C, Rothé F, Rorive S, Decaestecker C, Larsimont D, Piccart-Gebhart M, Biganzoli E, Sotiriou C, Willard-Gallo K
Year : 2017
Journal : Mod Pathol
Volume : 30(9)
Pages : 1204-1212

Can we omit radiotherapy in case of brain metastases for patients with mutant EGFR lung adenocarcinoma?

Authors : Van Houtte P, Devriendt D
Year : 2017
Journal : Transl Lung Cancer Res
Volume : 6
Pages : S71-S73

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies.

Authors : Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, Soria JC, Moshir M, Dreier T, Van Rompaey L, Michot JM, Silence K, Hultberg A, Gandini D, de Haard H, Ribrag V, Peeters M, Thibault A, Leupin N, Awada A
Year : 2017
Journal : Clin Cancer Res
Volume : 23(21)
Pages : 6411-6420

Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.

Authors : Lambertini M, Del Mastro L, Viglietti G, Pondé NF, Solinas C, de Azambuja E
Year : 2017
Journal : Curr Treat Options Oncol
Volume : 18
Pages : 4

P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.

Authors : Najem A, Krayem M, Sales F, Hussein N, Badran B, Robert C, Awada A, Journe F, Ghanem G
Year : 2017
Journal : Eur J Cancer
Volume : 83
Pages : 154-165

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

Authors : Gingras I, Holmes E, de Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart-Gebhart M, Azim HA Jr
Year : 2017
Journal : J Natl Cancer Inst
Volume : 109

The EORTC module for quality of life in patients with thyroid cancer: phase III.

Authors : Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araujo C, Hammerlid E, Vidhubala E, Husson O, Kiyota N, Brannan C, Salem D, Gamper E, Arraras JI, Ioannidis G, Andry G, Inhestern J, Gregoire V, Licitra L
Year : 2017
Journal : Endocr Relat Cancer
Volume : 24(4)
Pages : 197-207

Editorial.

Authors : Berghmans T
Year : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 3

Genomic Evolution of Breast Cancer Metastasis and Relapse.

Authors : Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M, Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C, Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW, Richardson AL, Tutt A, Lønning PE, Campbell PJ
Year : 2017
Journal : Cancer Cell
Volume : 32
Pages : 169-184.e7

Immunotherapy and non-small cell lung cancer : a (r)evolution.

Authors : Berghmans T, Meert AP
Year : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 175-177

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Authors : Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS
Year : 2017
Journal : Breast Cancer Res Treat
Volume : 163(3)
Pages : 535-544

Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.

Authors : Artesi M, Marçais A, Durkin K, Rosewick N, Hahaut V, Suarez F, Trinquand A, Lhermitte L, Asnafi V, Avettand-Fenoel V, Burny A, Georges M, Hermine O, Van den Broeke A
Year : 2017
Journal : Leukemia
Volume : 31
Pages : 2532-35